Insulin metabolism and the risk of Alzheimer disease: The Rotterdam Study

Schrijvers, E.M.C., Witteman, J.C.M., Sijbrands, E.J.G., Hofman, A., Koudstaal, P.J., Breteler, M.M.B.·2010·Neurology

Cited by (328)

Items 301–328 of 328

  1. Endocrine and diagnostic aspects of cognitive impairment with special reference to Alzheimer’s disease
    Per Johansson · 2013 · Lund University Publications (Lund University)
  2. SLEEP ALTERATIONS IN MOUSE GENETIC MODELS OF HUMAN DISEASE
    Sethi, Mansi · 2016 · UKnowledge (University of Kentucky)
  3. Neurochemical Aspects of β-Amyloid Cascade Hypothesis for Alzheimer’s Disease
    A. A. Farooqui · 2017 · Elsevier eBooks
  4. The Effect Of Oil Palm Phenolics (opp) And Curcumin On Plasma Metabolomic Profile In Atherogenic Diet Induced Rat Model Of Alzheimer’s Disease (ad)
    Soniya Katekar · 2017 · Human Biology
  5. The Role of Insulin Resistance and Signaling in Dementia
    Aaron M. Koenig, Zoe Arvanitakis, Steven Edward Arnold · 2018 · Elsevier eBooks
  6. Chronic consumption of a high-fat diet: investigation of negative consequences
    Daniel W. Vigil · 2018 · Purdue e-Pubs (Purdue University System)
  7. Expression of MAPK and Inflammasomes in Brain Cells in Experimental Alzheimer’s Disease
    Yana V. Gorina, Olga L. Lopatina, Yulia K. Komleva, А. И. Черных, Alla B. Salmina · 2018 · Human Physiology
  8. Hormones of energy homeostasis : linking weight loss and cognition in Parkinson's disease?
    Fionnuala Johnston · 2018
  9. Using contextual clues in guessing foreign language vocabulary meaning
    Rahmani Sebti · 2017
  10. Mammalian target of rapamycin complexes
    Henry W. Querfurth, Hankyu Lee · 2020 · Elsevier eBooks
  11. TOR-dependent cerebrovascular aging in Alzheimer's disease.
    Jordan B. Jahrling, Verónica Galván · 2014 · PubMed
  12. Analogues du GLP-1 et éducation du patient diabétique de type 2
    F. Lagrange · 2011 · Le Pharmacien Hospitalier
  13. Agonisti del recettore del GLP1 e infiammazione: non solo compenso glicemico
    Gabriele Costanzo, Francesco Frasca · 2022 · L Endocrinologo
  14. Insulin Resistance’s Impact on Cognition in Middle Aged Adults from the PREVENT cohort: Interactive Effects with Depression
    Sarah Bauermeister, Graham Reid, Michael Ben Yehuda, Gregory Howgego, Karen A. Ritchie, Tam J. Watermeyer, Sarah Gregory, Graciela Muniz Terrera, Ivan G. Koychev · 2023 · medRxiv
  15. Impact of vitamin A on the risk of mild cognitive impairment and Alzheimer's disease pathology in high‐fat‐diet–treated APP/PS1 mice
    Xixiang Wang, Yujie Guo, Pengfei Li, Xiaojun Ma, Jingjing Xu, Lu Liu, Yu Liu, Xiuwen Ren, Ying Wang, Liping Meng et al. · 2024 · Food Frontiers
  16. Transforming Alzheimer's Treatment: Unveiling New Potential with Drug Repurposing Strategies
    Ashish Sriram Mishra, M. Vasanthan M. Vasanthan, Bhavna Ghosh, Ponnurengam Malliappan Sivakumar · 2025 · Current Medicinal Chemistry
  17. Neuroprotective potential of novel CARTp analogs in the hippocampus of THY-Tau22 mouse model of Tau pathology
    Vilém Charvát, Petra Vaculová, Blanka Železná, Lenka Maletı́nská, Andrea Pačesová · 2025 · Neuropharmacology
  18. TyG Index and Cognitive Decline in Non-diabetic Elderly: Evidence from CLHLS 2014-2018
    Diwen Shen, Qi Qian, Yang Liu, Hailong Yang, Junjun Liu, Xiangdong Du · 2025 · Research Square
  19. Transcriptional profiles reveal deregulation of lipid metabolism and inflammatory pathways in neurons exposed to palmitic acid
    Manuel Flores Leon, Nicolas Alcaraz Millman, Martha Pérez‐Domínguez, Karla Marisa Torres Arciga, Rosa Rebollar Vega, Inti Alberto De la Rosa Velazquez, Cristian Arriaga Canon, Luis A Herrera, Clorinda Arias, Rodrigo González Barrios · 2021 · Research Square
  20. Additional file 2 of Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer’s subjects?
    Grazia Daniela Femminella, Livingston, Nicholas R., Sanara Raza, Thalia F. van der Doef, Eleni Frangou, Sharon Love, Gail Busza, Valeria Calsolaro, Stefan Carver, Clive Holmes et al. · 2021 · Figshare
  21. Additional file 1 of The relationship of insulin resistance and diabetes to tau PET SUVR in middle-aged to older adults
    Gilda E. Ennis, Tobey J. Betthauser, Rebecca L. Koscik, Nathaniel A. Chin, Christian, Bradley T., Asthana, Sanjay, Johnson, Sterling C., Barbara B. Bendlin · 2023 · Figshare
  22. Semaglutide and the Effects of Glucagon-like Peptide-1 on Vision
    Rajesh Rajput, Hridish Narayan Chakravarti, Jothydev Kesavadev, RAJIV R. KOVIL, Siddhant Rajput · 2026 · International Journal of Diabetes and Technology
  23. Impact et réversibilité du syndrome métabolique et de ses composantes sur le vieillissement cognitif et le risque de démence
    Natacha Lévi · 2012
  24. Diabète et risque de démence
    Éric Frison · 2019
  25. D-chiro-inositol modulates brain insulin-related signaling and reduces amyloid burden, neuroinflammation and cognitive decline in preclinical models of Alzheimer's disease
    Beatriz Pacheco-Sánchez, Antonio J. López-Gambero, Ana Gavito, Patricia Rivera, Juan Suárez, Carlos Sanjuan, Per Nilsson, Simone Tambaro, Fernando Rodrı́guez de Fonseca · 2026 · Biomedicine & Pharmacotherapy
  26. Hypothalamus Amyloid Levels Are Associated with Early Sex-Dependent Alterations in Peripheral Energy Homeostasis in TgF344-AD Rats
    Caleb M. Levine, Cameron Caggiano, Thea Anderson, Michael A. Kelberman, David Weinshenker, Hannah Land Lail, Desiree Wanders, Debra A. Bangasser, Scott E. Kanoski, Marise B. Parent · 2026 · Molecular Neurobiology
  27. Cross-sectional associations of cumulative triglyceride-glucose index with cognitive function and mild cognitive impairment: Evidence from two community-based cohorts
    Lixin Ma, Yanjun Ma, Chaofan Geng, Ying Zhang, Zhibin Wang, Yiwei Zhao, Xue Gao, Yansu Guo, Lina Ma, Yi Tang · 2026 · Journal of Alzheimer s Disease
  28. Endocrine and diagnostic aspects of cognitive impairment
    Per Johansson · 2013 · Gothenburg University Publications Electronic Archive (Gothenburg University)